ResourceLife Sciences
Cytomegalovirus: The role of antibodies in advancing CMV diagnostics
10 Oct 2025The Native Antigen Company offers a comprehensive range of recombinant antigens and monoclonal antibodies for advancing cytomegalovirus (CMV) diagnostics and vaccine development. Featuring the newly developed recombinant human CMV glycoprotein B (gB) and PP65 antigens, along with six high-quality anti-CMV antibodies, these reagents provide superior sensitivity, specificity, and reproducibility. Ideal for use in ELISA, Western blot, immunofluorescence, and flow cytometry, these products enable reliable detection and immune response analysis in CMV research.
Links
Tags
ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.Vaccine DevelopmentVaccine development focuses on creating immunizations to protect against infectious diseases. The process involves identifying antigens, developing and testing vaccine efficacy, and ensuring safety through preclinical testing and multiple clinical trial phases. Scientists use various approaches, including weakened or inactivated viruses, protein subunits, or mRNA. Advanced platforms and rapid diagnostic tools aid in vaccine research and testing. Explore vaccine development solutions in our peer-reviewed product directory; compare products, read reviews, and get pricing directly from manufacturers. CMVCytomegalovirus